DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 134 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $113,000 | -45.4% | 28,374 | 0.0% | 0.00% | -66.7% |
| Q1 2019 | $207,000 | -20.4% | 28,374 | 0.0% | 0.00% | -40.0% |
| Q4 2018 | $260,000 | -26.1% | 28,374 | 0.0% | 0.01% | -44.4% |
| Q3 2018 | $352,000 | -18.7% | 28,374 | 0.0% | 0.01% | -25.0% |
| Q2 2018 | $433,000 | -23.1% | 28,374 | 0.0% | 0.01% | -40.0% |
| Q1 2018 | $563,000 | +6.2% | 28,374 | +0.2% | 0.02% | -4.8% |
| Q4 2017 | $530,000 | -13.0% | 28,324 | 0.0% | 0.02% | -25.0% |
| Q3 2017 | $609,000 | +123.1% | 28,324 | 0.0% | 0.03% | +115.4% |
| Q2 2017 | $273,000 | +61.5% | 28,324 | 0.0% | 0.01% | +85.7% |
| Q1 2017 | $169,000 | +33.1% | 28,324 | -11.7% | 0.01% | +16.7% |
| Q4 2016 | $127,000 | -51.0% | 32,074 | +30.3% | 0.01% | -53.8% |
| Q3 2016 | $259,000 | – | 24,624 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |